Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 March 2019
|
| In: |
Hematological oncology
Year: 2019, Jahrgang: 37, Pages: 319-322 |
| ISSN: | 1099-1069 |
| Online-Zugang: | Verlag, Volltext: https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2603
|
| Verfasserangaben: | Evgenji Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Getrud Wiedemann, Anne Angelillo-Scherrer, Lorenz Trümper, Martin Fiedler, Barbara Jeker, Ursula Amstutz, Thomas Pabst, Ulrike Bacher |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1687899800 | ||
| 003 | DE-627 | ||
| 005 | 20220817210521.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200120s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hon.2603 |2 doi | |
| 035 | |a (DE-627)1687899800 | ||
| 035 | |a (DE-599)KXP1687899800 | ||
| 035 | |a (OCoLC)1341298420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations |c Evgenji Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Getrud Wiedemann, Anne Angelillo-Scherrer, Lorenz Trümper, Martin Fiedler, Barbara Jeker, Ursula Amstutz, Thomas Pabst, Ulrike Bacher |
| 264 | 1 | |c 8 March 2019 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.01.2020 | ||
| 700 | 1 | |a Shumilov, Evgenii |e VerfasserIn |0 (DE-588)1195187599 |0 (DE-627)1677355387 |4 aut | |
| 700 | 1 | |a Flach, Johanna |d 1981- |e VerfasserIn |0 (DE-588)1079534865 |0 (DE-627)841212139 |0 (DE-576)451495330 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hematological oncology |d New York, NY [u.a.] : Wiley Interscience, 1983 |g 37(2019), Seite 319-322 |h Online-Ressource |w (DE-627)320412040 |w (DE-600)2001443-0 |w (DE-576)114617414 |x 1099-1069 |7 nnas |a Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations |
| 773 | 1 | 8 | |g volume:37 |g year:2019 |g pages:319-322 |g extent:4 |a Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2603 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200120 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1079534865 |a Flach, Johanna |m 1079534865:Flach, Johanna |d 60000 |d 61200 |e 60000PF1079534865 |e 61200PF1079534865 |k 0/60000/ |k 1/60000/61200/ |p 2 | ||
| 999 | |a KXP-PPN1687899800 |e 3576891315 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1687899800","note":["Gesehen am 20.01.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations","title_sort":"Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations"}],"person":[{"roleDisplay":"VerfasserIn","display":"Shumilov, Evgenii","role":"aut","family":"Shumilov","given":"Evgenii"},{"display":"Flach, Johanna","roleDisplay":"VerfasserIn","role":"aut","family":"Flach","given":"Johanna"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1099-1069"],"eki":["320412040"],"doi":["10.1002/(ISSN)1099-1069"],"zdb":["2001443-0"]},"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedKey":"1983","publisher":"Wiley Interscience","dateIssuedDisp":"1983-"}],"language":["eng"],"recId":"320412040","note":["Gesehen am 27.02.08"],"disp":"Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutationsHematological oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"4","volume":"37","text":"37(2019), Seite 319-322","pages":"319-322","year":"2019"},"pubHistory":["1.1983 -"],"title":[{"title_sort":"Hematological oncology","title":"Hematological oncology"}]}],"physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1002/hon.2603"],"eki":["1687899800"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"8 March 2019"}],"name":{"displayForm":["Evgenji Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Getrud Wiedemann, Anne Angelillo-Scherrer, Lorenz Trümper, Martin Fiedler, Barbara Jeker, Ursula Amstutz, Thomas Pabst, Ulrike Bacher"]}} | ||
| SRT | |a SHUMILOVEVCRITICALEV8201 | ||